AstraZeneca pays CSPC $100M for preclinical heart disease drug, teeing up combos and Lilly rivalry

AstraZeneca pays CSPC $100M for preclinical heart disease drug, teeing up combos and Lilly rivalry ntaylor Mon, 10/07/2024 - 06:14